Oxidized ApoC1 on MALDI-TOF and glycated-ApoA1 band on gradient gel as potential diagnostic tools for atherosclerotic vascular disease.

作者: Chiz-Tzung Chang , Hsin-Yi Liao , Chia-Ming Chang , Chia-Ying Chen , Chu-Huang Chen

DOI: 10.1016/J.CCA.2012.10.017

关键词:

摘要: Abstract Background Atherosclerotic vascular disease (ASVD), including coronary artery disease, ischemic stroke, and peripheral is the most common cause of death both in general population high-risk patients; patients with diabetes mellitus (DM), uremia (UM), primary hyperlipidemia (HP) have increased risks for developing ASVD. Methods To identify new biomarkers early prediction ASVD, HDL samples from (ASVD) but no documented ASVD (non-ASVD) were collected Bis-Tris gradient gel MALDI-TOF (matrix-assisted laser desorption ionization-time flight) analyses. Results Oxidation ApoC1 was detected specifically by MALDI-TOF. On gel, non-ASVD ApoA1 displayed into 2 distinct bands A B. An additional C band appeared exclusively patients. The extraordinary characterized high levels glycation oxidation. analyses peptides after trypsin digestion confirmed higher oxidation than samples. Conclusions Gel identification highly-glycated oxidized detection may provide a approach diagnosis.

参考文章(50)
Mark J Sarnak, Andrew S Levey, Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease. Journal of Thrombosis and Thrombolysis. ,vol. 10, pp. 169- 180 ,(2000) , 10.1023/A:1018718727634
R M Benitez, R A Vogel, Noninvasive assessment of cardiovascular risk: from Framingham to the future. Reviews in Cardiovascular Medicine. ,vol. 1, pp. 34- 42 ,(2000)
Matthew S. Wroblewski, Joshua T. Wilson-Grady, Michael B. Martinez, Raj S. Kasthuri, Kenneth R. McMillan, Cristina Flood-Urdangarin, Gary L. Nelsestuen, A functional polymorphism of apolipoprotein C1 detected by mass spectrometry. FEBS Journal. ,vol. 273, pp. 4707- 4715 ,(2006) , 10.1111/J.1742-4658.2006.05473.X
Donghui Liu, Liang Ji, Dongmei Zhang, Xunliang Tong, Bing Pan, Pinli Liu, Youyi Zhang, Yining Huang, Jinzi Su, Belinda Willard, Lemin Zheng, Nonenzymatic glycation of high-density lipoprotein impairs its anti-inflammatory effects in innate immunity. Diabetes-metabolism Research and Reviews. ,vol. 28, pp. 186- 195 ,(2012) , 10.1002/DMRR.1297
Martin K. Jones, Andrea Catte, Ling Li, Jere P. Segrest, Dynamics of activation of lecithin:cholesterol acyltransferase by apolipoprotein A-I. Biochemistry. ,vol. 48, pp. 11196- 11210 ,(2009) , 10.1021/BI901242K
A. Hoang, A. J. Murphy, M. T. Coughlan, M. C. Thomas, J. M. Forbes, R. O’Brien, M. E. Cooper, J. P. F. Chin-Dusting, D. Sviridov, Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties Diabetologia. ,vol. 50, pp. 1770- 1779 ,(2007) , 10.1007/S00125-007-0718-9
, Philip Greenland, Joseph S. Alpert, George A. Beller, Emelia J. Benjamin, Matthew J. Budoff, Zahi A. Fayad, Elyse Foster, Mark. A. Hlatky, John McB. Hodgson, Frederick G. Kushner, Michael S. Lauer, Leslee J. Shaw, Sidney C. Smith, Allen J. Taylor, William S. Weintraub, Nanette K. Wenger, 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation. ,vol. 122, pp. 2748- 2764 ,(2010) , 10.1161/CIR.0B013E3182051B4C
Jimmy F. P. Berbée, Caroline C. van der Hoogt, Deepa Sundararaman, Louis M. Havekes, Patrick C. N. Rensen, Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL Journal of Lipid Research. ,vol. 46, pp. 297- 306 ,(2005) , 10.1194/JLR.M400301-JLR200
D’Vesharronne Moore, Catherine McNeal, Ronald Macfarlane, Isoforms of apolipoprotein C-I associated with individuals with coronary artery disease Biochemical and Biophysical Research Communications. ,vol. 404, pp. 1034- 1038 ,(2011) , 10.1016/J.BBRC.2010.12.105
Erica L. Brooks, Sarah Rosner Preis, Shih-Jen Hwang, Joanne M. Murabito, Emelia J. Benjamin, Margaret Kelly-Hayes, Paul Sorlie, Daniel Levy, Health Insurance and Cardiovascular Disease Risk Factors The American Journal of Medicine. ,vol. 123, pp. 741- 747 ,(2010) , 10.1016/J.AMJMED.2010.02.013